BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 7682752)

  • 1. Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
    Fleischman RA
    Am J Med Sci; 1993 Apr; 305(4):248-73. PubMed ID: 7682752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [GM-CSF and G-CSF: cytokines in clinical application].
    Ruef C; Coleman DL
    Schweiz Med Wochenschr; 1991 Mar; 121(12):397-412. PubMed ID: 1709294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical applications of human granulocyte-macrophage colony-stimulating factor.
    Sakamoto KM; Gasson JC
    Int J Cell Cloning; 1991 Nov; 9(6):531-41. PubMed ID: 1770227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hematopoietic growth factors in prophylaxis and therapy of infections complications in children with neutropenia].
    Lehrnbecher T
    Klin Padiatr; 2001; 213(4):212-38. PubMed ID: 11528556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use and toxicity of the colony-stimulating factors.
    Schriber JR; Negrin RS
    Drug Saf; 1993 Jun; 8(6):457-68. PubMed ID: 7687134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GM-CSF.G-CSF].
    Kitamura K
    Gan To Kagaku Ryoho; 1995 Feb; 22(2):301-5. PubMed ID: 7531964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte colony-stimulating factors.
    Med Lett Drugs Ther; 1991 Jun; 33(847):61-3. PubMed ID: 1710761
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical applications of granulocyte-colony stimulating factor.
    Sung L; Dror Y
    Front Biosci; 2007 Jan; 12():1988-2002. PubMed ID: 17127437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic use of granulocyte-macrophage colony-stimulating factor (GM-CSF). A review of recent experience.
    Costello RT
    Acta Oncol; 1993; 32(4):403-8. PubMed ID: 8369127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contrasting effects of recombinant human granulocyte-macrophage colony-stimulating factor (CSF) and granulocyte CSF treatment on the cycling of blood elements in childhood-onset cyclic neutropenia.
    Wright DG; Kenney RF; Oette DH; LaRussa VF; Boxer LA; Malech HL
    Blood; 1994 Aug; 84(4):1257-67. PubMed ID: 7519479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor: comparisons and potential for use in the treatment of infections in nonneutropenic patients.
    Root RK; Dale DC
    J Infect Dis; 1999 Mar; 179 Suppl 2():S342-52. PubMed ID: 10081506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF and GM-CSF in clinical trials.
    Antman KH
    Yale J Biol Med; 1990; 63(5):387-410. PubMed ID: 1705737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Report on the current indications for colony stimulating factors (G-CSF and GM-CSF)].
    Med Clin (Barc); 1994 May; 102(19):747-50. PubMed ID: 7518884
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications.
    Hill AD; Naama HA; Calvano SE; Daly JM
    J Leukoc Biol; 1995 Dec; 58(6):634-42. PubMed ID: 7499960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effect of granulocyte-macrophage colony-stimulating factor therapy on the generation of natural killer cells.
    Shibuya A; Taguchi K; Kojima H; Abe T
    Blood; 1991 Dec; 78(12):3241-7. PubMed ID: 1720700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Myeloid hemopoietic growth factors. Therapeutic possibilities and clinical experiences].
    Hansen B; Johnsen HE
    Ugeskr Laeger; 1990 Oct; 152(44):3232-7. PubMed ID: 1700524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
    Glaspy JA
    Oncology (Williston Park); 2003 Nov; 17(11):1593-603. PubMed ID: 14682110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.